Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01942837
Title Phase II Trial of Enzalutamide for Castrate-resistant Prostate Cancer With Correlative Assessment of Androgen Receptor Signaling
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Brigham and Women's Hospital Boston Massachusetts 02115 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02115 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
South Shore Hospital Weymouth Massachusetts 02190 United States Details
University of Washington Medical Center/Seattle Cancer Care Alliance Seattle Washington 98195 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field